Publications by authors named "Amar M Yeware"

Non-natural antimicrobial peptides are ideal as next-generation antibiotics because of their ability to circumvent the problems of drug resistance and in vivo instability. We report novel all-α- and α,γ-mixed Tat peptide analogues as potential antibacterial and anti-TB agents. These peptides have broad spectrum antibacterial activities against Gram-positive (MICs 0.

View Article and Find Full Text PDF

Superoxide generation is inevitable in aerobic organisms, most of which have developed mechanisms to detoxify superoxides. However, its significance has not been clearly understood in mycobacteria. This study demonstrates that NADH oxidase is the major source of superoxide in and elucidates the involvement of superoxide in growth.

View Article and Find Full Text PDF

Fluoroquinolones are third-generation broad spectrum bactericidal antibiotics and work against both Gram-positive and Gram-negative bacteria. Levofloxacin (L), a fluoroquinolone, is widely used in anti-infective chemotherapy and treatment of urinary tract infection and pneumonia. The main pathogen for urinary tract infections is Escherichia coli, and Streptococcus pneumoniae is responsible for pneumonia, predominantly a lower respiratory tract infection.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Amar M Yeware"

  • - Amar M Yeware's research focuses on developing novel antimicrobial peptides and prodrugs to combat drug-resistant bacterial infections, particularly targeting Gram-positive and Gram-negative bacteria, including Mycobacterium tuberculosis.
  • - His work highlights the potential of non-natural antimicrobial peptides as next-generation antibiotics, demonstrating their effectiveness against various strains of bacteria, including the exploration of mechanisms like superoxide generation in mycobacterial growth.
  • - Yeware's studies also emphasize the design of prodrugs, such as a targeted release mechanism for Levofloxacin, which showcases innovative approaches for enhancing treatment efficacy in prevalent infections like urinary tract infections and pneumonia.